Sun Pharmaceuticals Industries Ltd SUNPHARMA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SUNPHARMA is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- INR 1,506.55
- Day Range
- INR 1,510.05–1,527.80
- 52-Week Range
- INR 922.45–1,638.85
- Bid/Ask
- INR 1,524.75 / INR 1,524.85
- Market Cap
- INR 3.66 Tril
- Volume/Avg
- 600,955 / 2.8 Mil
Key Statistics
- Price/Earnings (Normalized)
- 38.24
- Price/Sales
- 7.75
- Dividend Yield (Trailing)
- 0.83%
- Dividend Yield (Forward)
- 0.83%
- Total Yield
- 0.83%
Company Profile
Sun Pharmaceuticals Industries Ltd is India's largest generic pharmaceutical manufacturer and the fourth largest in the world. The company’s largest markets are the U.S. and India to make up the majority of revenue. The remaining is spread across both emerging and developed markets. In addition to generics, the company also produces and distributes name-brand formulas to specific geographies. It maintains manufacturing and research and development facilities globally to serve its markets but is primarily based in India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Large Growth
- Total Number of Employees
- 19,021
- Website
- https://www.sunpharma.com
Comparables
Valuation
|
Metric
|
SUNPHARMA
|
543904
|
524816
|
|---|---|---|---|
Price/Earnings (Normalized) | 38.24 | — | 14.54 |
Price/Book Value | 6.04 | 11.26 | 3.49 |
Price/Sales | 7.75 | — | 4.87 |
Price/Cash Flow | 33.25 | — | 15.13 |
Price/Earnings
SUNPHARMA
543904
524816
Financial Strength
|
Metric
|
SUNPHARMA
|
543904
|
524816
|
|---|---|---|---|
Quick Ratio | 1.80 | 1.60 | 2.67 |
Current Ratio | 2.62 | 2.66 | 3.81 |
Interest Coverage | 41.80 | 32.14 | 138.30 |
Quick Ratio
SUNPHARMA
543904
524816
Profitability
|
Metric
|
SUNPHARMA
|
543904
|
524816
|
|---|---|---|---|
Return on Assets (Normalized) | — | 12.68% | — |
Return on Equity (Normalized) | — | 17.56% | — |
Return on Invested Capital (Normalized) | — | 16.41% | — |
Return on Assets
SUNPHARMA
543904
524816
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Flbfnbbzl | Xkb | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Ryjgpnxvf | Nzwjjc | $70.8 Bil | |
HLN
| Haleon PLC ADR | Kvvlqmpqs | Lxytv | $38.2 Bil | |
VTRS
| Viatris Inc | Bqrbvpbn | Wvkx | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Rhcnbnhl | Zlgpn | $12.5 Bil | |
CTLT
| Catalent Inc | Gxhblddl | Qjmlr | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Vyypjjvx | Ckzq | $4.3 Bil | |
CURLF
| Curaleaf Holdings Inc | Rdsgvwrxt | Sbdt | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Bgdjzdj | Rktws | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Bhvcpspxw | Fnhr | $2.9 Bil |